Sep 27, 2021 / 06:00PM GMT
Alethia Rene Young - Cantor Fitzgerald & Co., Research Division - Director of Equity Research & Head of Healthcare Research
Hey, everybody. It's Alethia Young here. I cover large-cap, small, mid-cap biotech here at Cantor. Very happy to have Amgen with us this afternoon. We have Peter Griffith, who's the Executive Vice President and CFO. We have Susan Sweeney, who is SVP of Global Marketing, Access and Capabilities. We have Arvind Sood, who needs no introduction but VP of IR; and we have Omari Wise, who's the Executive Director in the IR team as well.
So we'll be doing a fireside chat for the next 30 minutes, and I'm just going to dive right on in.
Questions and Answers:
Alethia Rene Young - Cantor Fitzgerald & Co., Research Division - Director of Equity Research & Head of Healthcare ResearchAnd so maybe this one is for Susan, perhaps. Just talk a little bit about how you collaborate with the commercial team to drive solutions that improve outcomes for patients and customers overall.
Susan Sweeney -
Trustpilot
